GlassScriptPhysician profile
Bapu C Aluri
NPI 1487762456
$16,307.11
in general payments reported to CMS, 2019-2025
63 companies · $2,657 in 2025
The $2,657 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,296 · 2020: $1,713 · 2021: $2,447 · 2022: $2,156 · 2023: $2,866 · 2024: $3,173 · 2025: $2,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,372 · Travel and Lodging: $287 · Education: $36.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,372.32 |
| Travel and Lodging | $287.00 |
| Education | $36.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,721.22 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Neurocrine Biosciences, INC. | $904.63 | 2019-2025 | Ingrezza, Ongentys |
| Eisai INC. | $875.93 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $841.43 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $773.80 | 2019-2025 | |
| Ucb, INC. | $734.31 | 2022-2025 | Zilbrysq, Rystiggo, Nayzilam |
| Allergan, INC. | $723.99 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $619.60 | 2019-2025 | Ultomiris, Soliris |
| Medtronic, INC. | $538.51 | 2021-2024 | Percept PC Brainsense, Sensight |
| Biogen, INC. | $498.81 | 2019-2025 | Vumerity, Tysabri |
| Lilly USA, LLC | $465.78 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Genzyme Corporation | $440.75 | 2019-2023 | |
| Sk Life Science, INC. | $355.13 | 2020-2025 | |
| Neurelis, INC. | $311.92 | 2020-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $296.57 | 2019-2025 | Nuplazid |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $286.15 | 2023-2025 | Acthar |
| Lundbeck LLC | $282.36 | 2020-2025 | Vyepti, Rexulti |
| Catalyst Pharmaceuticals, INC. | $262.48 | 2022-2025 | Fycompa, Firdapse |
| Sumitomo Pharma America, INC. | $243.75 | 2023-2024 | Aptiom |
| Amneal Pharmaceuticals LLC | $235.02 | 2019-2025 | Rytary, Crexont |
| Pfizer INC. | $230.76 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $210.41 | 2022-2025 | Spravato |
| Amgen INC. | $203.15 | 2019-2025 | Uplizna |
| Sunovion Pharmaceuticals INC. | $193.95 | 2019-2022 | |
| Boston Scientific Corporation | $177.93 | 2020-2023 | |
| Neuronetics, INC. | $176.01 | 2019-2024 | Neurostar Tms Therapy System |
| Genentech USA, INC. | $164.43 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Argenx US, INC. | $164.42 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Upsher-Smith Laboratories LLC | $157.15 | 2020-2021 | |
| Travere Therapeutics, INC. | $134.84 | 2019-2023 | Cholbam |
| Csl Behring | $128.05 | 2020-2025 | Hizentra |
| Acorda Therapeutics, INC | $126.46 | 2020-2022 | |
| Tg Therapeutics, INC. | $126.30 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $125.00 | 2024-2025 | Purified Cortrophin Gel |
| Supernus Pharmaceuticals, INC. | $120.73 | 2019-2020 | |
| Horizon Therapeutics Plc | $117.24 | 2021-2023 | Uplizna |
| Abbott Laboratories | $101.96 | 2020-2024 | Infinity |
| Biohaven Pharmaceutical Holding Company LTD. | $99.32 | 2022 | |
| Greenwich Biosciences, INC. | $93.76 | 2020-2021 | |
| Tanabe Pharma America, INC. | $87.65 | 2019-2023 | |
| Banner Life Sciences, LLC | $81.74 | 2022-2024 | |
| Medtronic USA, INC. | $76.91 | 2019-2020 | |
| Kyowa Kirin, INC. | $71.64 | 2020-2021 | |
| Merz Pharmaceuticals, LLC | $68.56 | 2025 | Xeomin, Inbrija, Ampyra |
| Jazz Pharmaceuticals INC. | $66.40 | 2023-2024 | |
| Grifols USA, LLC | $62.49 | 2023-2024 | Gamunex-C |
| Livanova USA, INC. | $60.46 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $51.96 | 2024-2025 | Rexulti |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.65 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $38.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $33.06 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.04 | 2022-2023 | |
| Electromed, INC. | $32.59 | 2021-2023 | Smartvest |
| Alnylam Pharmaceuticals INC. | $30.64 | 2022-2023 | Amvuttra |
| Nevro Corp. | $29.91 | 2022-2023 | Senza |
| Arbor Pharmaceuticals, INC. | $29.42 | 2019-2020 | |
| Averitas Pharma INC. | $27.53 | 2024 | Qutenza |
| Xeris Pharmaceuticals, INC. | $22.92 | 2021 | |
| Emd Serono, INC. | $22.64 | 2023 | Mavenclad |
| Harmony Biosciences LLC | $19.28 | 2023 | Wakix |
| Mirati Therapeutics, INC. | $16.79 | 2024 | Krazati |
| Corium, LLC | $16.55 | 2022 | |
| Axsome Therapeutics, INC. | $13.70 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bapu Aluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.